Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HELICOS BIOSCIENCES CORP | 10,709,818 | reported | 18 Sept 2009 | tx 24+16,193,529−9,269,568 |
| CERO THERAPEUTICS HOLDINGS, INC. | 1,612,099 | reported | 07 Jan 2026 | tx 28+25,456,506−1,332,815 |
| Inogen Inc | 56,127 | reported | 07 Jan 2015 | tx 14+214,937−921,263 |
| Clovis Oncology, Inc. | 42,223 | reported | 10 Jun 2021 | tx 35+2,560,929−531,454 |
| Locust Walk Acquisition Corp. | 25,000 | reported | 12 Jan 2021 | tx 1−25,000 |
| PHASERX, INC. | 14,000 | reported | 25 May 2017 | tx 8+642,203−258,044 |
| OPGEN INC | 12,500 | reported | 22 Jun 2016 | tx 9+2,907,450−2,068,286 |
| FIVE PRIME THERAPEUTICS INC | 12,500 | reported | 12 Jun 2015 | tx 7+1,117,152−1,015,229 |
| Atreca, Inc. | 12,000 | reported | 13 Jun 2023 | tx 13+115,457−67,457 |
| VERACYTE, INC. | 10,000 | reported | 20 Jun 2016 | tx 11+18,111,107 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 1,612,099 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 122,549 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | CERO THERAPEUTICS HOLDINGS, INC. | 294,460 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | CERO THERAPEUTICS HOLDINGS, INC. | 294,460 | 0.00 USD | deriv |
| 04 Mar 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 14,936 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 254,000 | 0.00 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 306,120 | 0.00 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 204,080 | 1.96 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 306,120 | 1.96 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 204,080 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 254,000 | 0.00 USD | deriv |
| 25 Sept 2024 | EXERCISE | CERO THERAPEUTICS HOLDINGS, INC. | 19,358,578 | — | |
| 30 Sept 2024 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 13,857 | 0.00 USD | deriv |
| 25 Sept 2024 | EXERCISE | CERO THERAPEUTICS HOLDINGS, INC. | 1,002 | 1000.00 USD | deriv |
| 30 Sept 2024 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 1,317,956 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 1,317,956 | 0.00 USD | deriv |
| 14 Feb 2024 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 125,000 | — | |
| 14 Feb 2024 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 100,527 | — | |
| 14 Feb 2024 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 148,208 | — | |
| 14 Feb 2024 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 1,002 | 1000.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Atreca, Inc. | 12,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Atreca, Inc. | 12,000 | 0.00 USD | deriv |
| 08 Oct 2021 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 25,000 | — | deriv |
| 09 Jun 2021 | GRANT_AWARD | Atreca, Inc. | 12,000 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Clovis Oncology, Inc. | 42,223 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 23 May 2016.